| Diana L. Carriger Optometrist Llc | |
|
1001 Sw Mulvane St, Topeka, KS 66604-1419 | |
| (785) 234-3937 | |
| (785) 234-1577 |
| Full Name | Diana L. Carriger Optometrist Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1001 Sw Mulvane St, Topeka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174634539 | NPI | - | NPPES |
| CE0587 | Other | KS | RAILROAD MEDICARE |
| 0599730001 | Other | KS | MEDICARE NSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana L. Carriger Optometrist Llc 1001 Sw Mulvane St, Topeka, KS 66604-1419 Ph: (785) 234-3937 | Diana L. Carriger Optometrist Llc 1001 Sw Mulvane St, Topeka, KS 66604-1419 Ph: (785) 234-3937 |
News Archive
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced data from a preclinical study on the erythropoietin (EPO) receptor agonist LG5640 at the upcoming 52nd American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida at the Orange County Convention Center, December 4 - 7, 2010.
Girls and young women who post sexy or revealing photos on social media sites such as Facebook are viewed by their female peers as less physically and socially attractive and less competent to perform tasks, a new study from Oregon State University indicates.
New positive Phase II results from an interim analysis of the randomised Phase I/II study involving the company's investigational haematology/oncology compound volasertib in newly diagnosed patients with acute myeloid leukemia (AML) considered ineligible for intensive remission induction therapy were presented at the 54th American Society of Hematology (ASH) annual meeting in Atlanta, USA.
According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control the signs and symptoms of juvenile idiopathic arthritis, despite the availability of several approved biologic disease-modifying antirheumatic drugs (biologics).
› Verified 7 days ago
Dr. Jason Manes, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2008 Sw Gage Blvd, Topeka, KS 66604 Phone: 785-354-8383 | |
Heather Kristine Polson, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2144 Sw 36th St, Topeka, KS 66611 Phone: 785-266-1010 Fax: 785-266-5312 | |
Dr. Michael Patrick Malone, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2144 Sw 36th St, Topeka, KS 66611 Phone: 785-266-1010 | |
Adventure Dental And Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: 400 Sw 29th St., Suite M, Topeka, KS 66611 Phone: 785-783-5981 Fax: 785-783-5982 | |
Dr. Michael Thomas Smith, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1107 Sw Gage Blvd., Topeka, KS 66604 Phone: 785-271-8989 | |
Kate Hamm Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1801 Sw Wanamaker Rd, Topeka, KS 66604 Phone: 785-272-1866 | |
Chris A Deutscher, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1140 Sw Fairlawn Rd, Topeka, KS 66604 Phone: 785-235-2374 Fax: 785-232-0136 |